Jaguar Health CSO and Investigators Discuss Crofelemer at Dubai Conference
The company says it is targeting an NDA filing for crofelemer in microvillus inclusion disease.
The company says it is targeting an NDA filing for crofelemer in microvillus inclusion disease.